These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2126034)

  • 1. Impact of surfactant treatment on cost of neonatal intensive care: a cost-benefit analysis.
    Merritt TA; Hallman M; Vaucher Y; McFeeley E; Tubman TR
    J Perinatol; 1990 Dec; 10(4):416-9. PubMed ID: 2126034
    [No Abstract]   [Full Text] [Related]  

  • 2. Economic consequences of surfactant therapy.
    Eidelman AI
    J Perinatol; 1993; 13(2):137-9. PubMed ID: 8515307
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost effectiveness of prevention and treatment of neonatal respiratory distress (RDS) with exogenous surfactant: what has changed in the last three decades?
    Mugford M
    Early Hum Dev; 2006 Feb; 82(2):105-15. PubMed ID: 16457971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous surfactant in neonatal respiratory distress syndrome.
    Cashore WJ
    R I Med; 1995 Jan; 78(1):7-10. PubMed ID: 7873814
    [No Abstract]   [Full Text] [Related]  

  • 5. Surfactant replacement therapy.
    Yu V
    Indian Pediatr; 1998 Nov; 35(11):1081-96. PubMed ID: 10216542
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of surfactant for respiratory distress syndrome.
    Mallamo K
    Neonatal Netw; 1999 Oct; 18(7):43. PubMed ID: 10808888
    [No Abstract]   [Full Text] [Related]  

  • 7. Surfactant and the neonatal lung.
    Gibson AT
    Br J Hosp Med; 1997 Oct 15-Nov 4; 58(8):381-4, 397. PubMed ID: 9509038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic impact of porcine surfactant replacement (Curosurf) for severe neonatal respiratory distress syndrome.
    Tubman TR; Halliday HL; Normand C
    J Perinat Med; 1991; 19 Suppl 1():403-7. PubMed ID: 1779394
    [No Abstract]   [Full Text] [Related]  

  • 9. Economic outcome for intensive care of infants of birthweight 500-999 g born in Victoria in the post surfactant era. The Victorian Infant Collaborative Study Group.
    J Paediatr Child Health; 1997 Jun; 33(3):202-8. PubMed ID: 9259293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of respiratory distress syndrome: an update.
    Rodriguez RJ
    Respir Care; 2003 Mar; 48(3):279-86; discussion 286-7. PubMed ID: 12667277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dilemmas of surfactant replacement.
    Robertson B
    J Perinat Med; 1991; 19 Suppl 1():183-8. PubMed ID: 1779356
    [No Abstract]   [Full Text] [Related]  

  • 12. Babies breathing.
    Black Monsen R
    J Pediatr Nurs; 2005 Feb; 20(1):45-6. PubMed ID: 15834358
    [No Abstract]   [Full Text] [Related]  

  • 13. Surfactant therapy in neonatal respiratory distress syndrome.
    Nagesh K; Bhat V; Kunikullaya S; Rajesh N
    Indian Pediatr; 1994 Aug; 31(8):971-7. PubMed ID: 7883350
    [No Abstract]   [Full Text] [Related]  

  • 14. Exogenous surfactant therapy in newborns.
    Rodriguez RJ; Martin RJ
    Respir Care Clin N Am; 1999 Dec; 5(4):595-616. PubMed ID: 10565883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surfactant replacement therapy: development of criteria for appropriate use. Ohio State University Hospitals.
    Gardner DK
    Hosp Formul; 1992 Aug; 27(8):821-2, 825-6, 828-30 passim. PubMed ID: 10119517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of surfactant replacement therapy on the nursery.
    Nightengale B
    Neonatal Netw; 1992 Jun; 11(4):xiii-xvi. PubMed ID: 1608368
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of natural surfactants to prevent and treat respiratory distress syndrome.
    Spafford PS; Kendig JW; Maniscalco WM
    Semin Perinatol; 1993 Aug; 17(4):285-94. PubMed ID: 8140443
    [No Abstract]   [Full Text] [Related]  

  • 18. HFV: applied technology, saving both lives and costs.
    Bachman T; Lassen G
    Neonatal Intensive Care; 1993; 6(5):34-8. PubMed ID: 10146589
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost of surfactant replacement treatment for severe neonatal respiratory distress syndrome: a randomised controlled trial.
    Tubman TR; Halliday HL; Normand C
    BMJ; 1990 Oct; 301(6756):842-5. PubMed ID: 2126475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exogenous surfactant therapy: newer developments.
    Lacaze-Masmonteil T
    Semin Neonatol; 2003 Dec; 8(6):433-40. PubMed ID: 15001115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.